Recent executive movements at Contextual Genomics

Sue Paish, who was Director, is promoted to Chairman of the Board  (news posted on May 7 2019).
Michael Ball has joined the company as Chief Executive Officer  (news posted on March 14 2019).

Create an alert
to follow the executive moves at Contextual Genomics.

Latest M&A news in Biotechnology.

WebMD Health has announced the acquisition of Aptus Health (posted on Sep 30, 2019).
Castle Creek Pharmaceuticals has announced the acquisition of Fibrocell Science (posted on Sep 13, 2019).
Medicine Man Technologies has announced the acquisition of MedPharm (posted on Sep 12, 2019).

Most searched biographies at Contextual Genomics

• Michael Ball, Chief Executive Officer and Director
• James Lumsdaine, Director
• Sue Paish, Chairman of the Board

Click on an executive to view his biography >

Other contacts in the Biotechnology industry

• Fred Cohen - Director at UroGen
• Sylke Hassel - Senior Vice President and Global Head of Mammalian Busines at Lonza
• Catherine Courboillet - Chief Executive Officer at Cerba Healthcare

Learn more about the Biotechnology industry >

Latest news about Contextual Genomics

Contextual Genomics on Wikipedia, Google News & Yahoo Finance

Contextual Genomics on LinkedIn, Twitter & YouTube

Contextual Genomics has 1,315 competitors including Aldeyra Therapeutics (United States (USA)), Generation Bio (United States (USA)) and Alltech (United States (USA)). Contextual Genomics is owned by LifeLabs.

Contact by email its executives including Alicja Parker

Call Contextual Genomics at +1 778....

View the org chart

Register to receive your alert

Report an error